Literature DB >> 8125008

Hypothermia, a pertinent clinical prognostic factor in severe systemic inflammatory response syndrome.

F Brivet, P M Carras, J Dormont, B Guidet, G Offenstadt, B Gachot, M Wolf, J F Timsit, B Misset.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8125008     DOI： 10.1097/00003246-199403000-00029

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  5 in total

1.  Management of severe infections: A time to keep a cool head or a hot topic for clinical trials?

Authors:  Kevin B Laupland; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

2.  Admission Body Temperature in Critically Ill Patients as an Independent Risk Predictor for Overall Outcome.

Authors:  Ralf Erkens; Bernhard Wernly; Maryna Masyuk; Johanna M Muessig; Marcus Franz; Paul Christian Schulze; Michael Lichtenauer; Malte Kelm; Christian Jung
Journal:  Med Princ Pract       Date:  2019-12-02       Impact factor: 1.927

Review 3.  Body temperature abnormalities in non-neurological critically ill patients: a review of the literature.

Authors:  Shigeki Kushimoto; Satoshi Yamanouchi; Tomoyuki Endo; Takeaki Sato; Ryosuke Nomura; Motoo Fujita; Daisuke Kudo; Taku Omura; Noriko Miyagawa; Tetsuya Sato
Journal:  J Intensive Care       Date:  2014-02-18

4.  The impact of body temperature abnormalities on the disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis.

Authors:  Shigeki Kushimoto; Satoshi Gando; Daizoh Saitoh; Toshihiko Mayumi; Hiroshi Ogura; Seitaro Fujishima; Tsunetoshi Araki; Hiroto Ikeda; Joji Kotani; Yasuo Miki; Shin-ichiro Shiraishi; Koichiro Suzuki; Yasushi Suzuki; Naoshi Takeyama; Kiyotsugu Takuma; Ryosuke Tsuruta; Yoshihiro Yamaguchi; Norio Yamashita; Naoki Aikawa
Journal:  Crit Care       Date:  2013-11-13       Impact factor: 9.097

5.  Cost-effectiveness of the TherMax blood warmer during continuous renal replacement therapy.

Authors:  Michael J Blackowicz; Max Bell; Jorge Echeverri; Kai Harenski; Marcus E Broman
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.